Loading stock data…
Scilex Holding Company (SCLX)
$5.37-0.05 (-0.83%)
Market ClosedLast close Sep 8
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Scilex Holding Company in the Healthcare sector is trading at $5.37 with a market capitalization of $53M. The stock is currently near its 52-week low of $2.62, remaining 17.4% below its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 21 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 25/100 signals elevated caution as multiple indicators diverge.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 21) — potential for technical mean-reversion
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $8.61M↑ | $4.79M↓ | $10.56M↑ | $9.90M↑ | $5.00M |
| Gross Profit | $4.17M↑ | $2.18M↓ | $7.23M↑ | $6.62M↑ | $3.62M |
| Operating Income | -$32.17M↑ | -$37.48M↑ | -$186.51M↓ | -$20.41M↑ | -$27.90M |
| Net Income | -$43.27M↓ | -$33.11M↑ | -$257.23M↓ | -$42.31M↓ | -$26.08M |
Peer Comparison
JNJUNHPFE
Fundamentals
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescript...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$52.54M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.71
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
150.84%
Volume
Today's trading volume
38,964
Recent News
Scilex, Vera Therapeutics rise premarket; Strategy gains
Investing.com - U.S. stock index futures edged higher on Monday as investors returned from a long holiday weekend, with technology shares leading gains.
Scilex Shares Jump After Securing $100 Million Strategic Investment Proposal (SCLX)
Binding Term Sheet Supports Growth PlansScilex Holding Company (NASDAQ:SCLX) shares climbed 7% on Monday after the company announced it had signed a binding term sheet for a proposed $100 million strategic investment from Kazakhstan-based private investment firm iHolding Group LLP. Under the proposed agreement, iHolding would acquire approximately 6.
Wellgistics Health, Datavault AI Agree to Form DelivMeds AI
Wellgistics Health (WGRX) and Datavault AI (DVLT) said Wednesday they have entered a binding term sh
Datavault AI Signs Binding Term Sheet for $120 Million Cash Contribution From Scilex
Datavault AI (DVLT) said Monday it has signed a binding term sheet for a cash contribution and reven
Trending tickers: Datavault, Novo Nordisk, FedEx, SBI and NatWest
The latest investor updates on stocks that are trending on Monday